Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cotimes Biotech is a specialized biotechnology company focused on the research, development, and production of high-end raw materials for nucleic acid drugs. The company provides a comprehensive suite of products, including phosphoramidites, modified nucleosides, and solid-phase synthesis supports like Controlled Pore Glass (CPG). In addition to its product portfolio, Cotimes offers Contract Development and Manufacturing Organization (CDMO) services for oligonucleotide and mRNA therapeutics. Based in China, the company supports the global life sciences industry by ensuring the supply of critical components for RNA-based medicine and gene therapy. Their manufacturing capabilities include GMP-compliant facilities that cater to both clinical and commercial scale requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cotimes Biotech.